The Future of Bioingredients
<aside> 🦛 We make allergy-friendly ingredients using cutting edge-biotechnology, enabling consumer-package good companies to offer to their customers an increase of palatability, nutrition and allergenicity at the same time (unlike alternatives where one or more is compromised).
</aside>
🎥 Hypoallergenic Formula Prototype
Rudy Ham-Zhu, MS MBA
CEO and Co-Founder
Quadrilingual biotechnology leader with 2 decades of experience in protein, immunotherapy, vaccine, and whole cell process development and production.
Technical lead behind the development, FDA/EMA/TGA approval and/or commercial launch of the COVID-19 vaccine (AstraZeneca), many proteins (DuPont and BASF), and immunotherapies (Atara).
Recognized as Top Voice on LinkedIn and Biotech Leader by Allbiotech. Rudy holds an MBA from the Quantic, MS in Biotechnology from Johns Hopkins University, and a BS in Biochemical Engineering from the University of California, Davis.
lhttps://www.linkedin.com/in/zhuam/
Guillermo Repizo, PhD
CSO and Co-Founder
Serial entrepreneur and, previously, co-founder of CasprBio, an IndieBio portfolio company sold to Amazon.
Over 20 years of experience in R&D and entrepreneurship, and backed up by more than 30 original research publications in peer reviewed journals and patent applications, Guillermo’s mission is to build and manage innovative projects in life sciences.
A Fulbright Fellow, Guillermo completed post-docs at the University of Chicago and the University of Groningen. In addition, he has a PhD in Biological Sciences from the National University of Rosario.
https://www.linkedin.com/in/guillermorepizo
There are more than 500 million people globally with food allergies, and its prevalence is increasing alarmingly 377% over a decade. For Rudy, the founder, this endeavor is deeply personal because his children have many food allergies.
The medical recommendation for people with food allergies is to avoid the allergens; however, having an allergen-free diet is inconvenient and restrictive at best. Most often, it is an extremely painful journey for families suffering from their limited options and the bad taste of current solutions.
A McKinsey report points out that the food allergy market is a “growing market [that] remains undeserved”, and we have confirmed this pain point with consumer packaged good companies like Nestlé. We discovered that the industry is fragmented: allergist medical doctors do not have good food recommendations, consumer packaged good companies are not interested in creating innovative ingredients, and ingredient companies typically do not have immunology or biotechnology expertise.
